What sector does Vaidya Sane Ayur Lab Ltd belong to?

Vaidya Sane Ayur Lab Ltd operates in the Healthcare sector, specifically the Medical Equipment & Supplies industry, and is listed on the NSE.

What is the current share price of MADHAVBAUG?

As of the latest available quote, MADHAVBAUG traded at ₹148.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of MADHAVBAUG?

Vaidya Sane Ayur Lab Ltd has a price-to-earnings (P/E) ratio of about 18.39. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of MADHAVBAUG?

The market capitalisation of Vaidya Sane Ayur Lab Ltd is approximately ₹168 Cr.

Is Vaidya Sane Ayur Lab Ltd profitable?

For its latest reported financial year, Vaidya Sane Ayur Lab Ltd recorded a net profit margin of about 8.41%.

Does MADHAVBAUG pay a dividend?

Vaidya Sane Ayur Lab Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of MADHAVBAUG?

Vaidya Sane Ayur Lab Ltd has a return on equity (ROE) of about 12.00%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of MADHAVBAUG?

Over the past 52 weeks, MADHAVBAUG has traded between a low of ₹147.00 and a high of ₹335.00.

Vaidya Sane Ayur Lab Ltd

MADHAVBAUG NSE Healthcare Medical Equipment & Supplies

₹148.00

-1.30%

Delayed · cached 15 min

Fair value analysis

MADHAVBAUG

Vaidya Sane Ayur Lab Ltd

₹158.95

Close used for this calculation

₹247.69Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

60/100

Profitability19/25

Returns13/25

Balance Sheet13/25

Efficiency15/25

Growth20/25

Good

Quality radar

Consensus fair value

₹247.69

Below FV

▲ +55.8% against the close used

Model range ₹124.83 – ₹385.06

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹124.83Fair value₹247.69Bull₹385.06

FairClose

52-week traded range

52W low ₹150.0052W high ₹298.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Vaidya Sane Ayur Lab Ltd closed at ₹158.95, 35.8% below the consensus fair value of ₹247.69 drawn from 9 valuation models.

Financial DNA score 60/100 — Good. P/E of 18.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹169.71

+6.8%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹126.53

-20.4%

√(22.5 × EPS × BVPS)

EPS=8.55, BVPS=83.22 · outside Graham range (P/E 18.6, P/B 1.9) — asset-light, treat as a rough floor

Graham Formula

₹385.06

+142.2%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹322.34

+102.8%

EPS × 37.7x (sector P/E)

EPS=8.55, Sector P/E=37.7x

Peter Lynch (PEG)

₹196.65

+23.7%

EPS × Growth% (PEG = 1 is fair)

EPS=8.55, g=23%

EV/EBITDA

₹354.80

+123.2%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=210M

Book Value (P/B)

₹124.83

-21.5%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=83.22, ROE=12%, g=6%, r=10%

Reverse DCF

₹158.95

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 6.2% | Historical: 23%

Margin of Safety

₹188.18

+18.4%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=250.91, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer